About usSign in

Action Potential Venture Capital

Status
ACTIVE
Global HQ
Scotts Valley, USA
Countries of investment
  • USA
  • Canada
Investment stages
  • Seed
  • Series A
  • Series B
Industries
  • Health Tech
  • Biotech
  • Pharmaceuticals
  • Medical Devices
  • Digital Health
About
Action Potential Venture Capital (APVC) is a leading medical technology venture capital firm founded by GSK in 2013. APVC invests globally and takes a handson role on the boards of startups advancing bioelectronic medicines and their enabling technologies. The firm is committed to fostering an inclusive and diverse workspace, contributing to a more equitable healthcare investor and entrepreneurial community. APVC's investment team expressly extends this commitment to the companies They invest in. APVC backs teams developing innovative medical and health tech solutions, focusing on transformative therapies and technologies aimed at improving patient outcomes.
Min check size
$100K
Max check size
$30M
Fund size
NPS

Investment Thesis

APVC is dedicated to bringing bioelectronic medicines to patients by supporting innovators and entrepreneurs pioneering a bioelectronic future.
Lead investor
Co Invest
Number of exits
Preferred contact method

Action Potential Venture Capital Contacts Information

Primary contact

Secondary contact

Team

Robert E. Glass

Partner

Brian Otis

Partner

Karl Johnson

Principal

Portfolio

Neuspera Medical

Cala

Exo

Alpheus Medical

Cala Health

CVRx

Exo Imaging

MicroTransponder

Neuspera

Onc AI

Presidio Medical

Saluda Medical

SetPoint Medical

Onc.ai

Allay Therapeutics

Avation Medical

Francis Medical

Health Scholars

Koya Medical

RareCyte

Fund number
Vintage Year
Net Internal Rate of Return
Investment Multiple
Capital Allocation
Management Fee
Carried Interest
AUM
Follow-on Investments
Graduation Rate
Write-Off Ratio
Last profile update timestamp